insulin

Afrezza

Pharma

FDA signs off on pediatric expansion for MannKind's Afrezza

The FDA has signed off on an expansion for MannKind's inhaled insulin Afrezza to be used by adolescents and children with Type 1 or Type 2 diabetes.

Kevin Dunleavy May 29, 2026 12:55pm

European Union flags waving in front of the EU Parliament building in Brussels

EU advances Critical Medicines Act to safeguard drug supply

May 12, 2026 9:13am

Insulin in a vial

Lilly plots European discontinuations of certain insulin products

Mar 24, 2026 11:52am

Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

Fierce Healthcare

FTC, Express Scripts reach settlement in insulin pricing case

Feb 4, 2026 12:35pm

Lantus

Sanofi expands price cut to $35 monthly for all insulin products

Sep 26, 2025 1:00pm

Lilly

With strong data, Lilly plots filings for weekly insulin asset

Jun 23, 2025 10:16am